
The Drug Discovery World Podcast
Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years.
DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go.
In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informatics; personalised medicine; screening; therapeutics, and much more.
For the podcast we have selected recent, relevant and popular scientific articles, so that you can listen to all of the best content from Drug Discovery World. We hope you enjoy.
Latest episodes

Sep 2, 2024 • 10min
DDW Highlights: 2 September 2024
Dive into groundbreaking advancements in drug discovery! Discover the international clinical trial exploring BioNTech’s mRNA lung cancer vaccine. Learn about innovative treatments making waves, including a monoclonal antibody and a new GLP-1 agonist for obesity. Plus, insights on a selective agonist for schizophrenia that could change lives. Join the buzz around these exciting clinical trials and the future of healthcare!

Aug 27, 2024 • 15min
DDW Highlights: 27 August 2024
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It’s been a busy week for medical regulatory agencies, with a number of key decisions made on therapies for graft-versus-host-disease, neuroendocrine carcinoma, haemophilia B, lymphoma and non-small cell lung cancer. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Aug 22, 2024 • 18min
How technology is impacting drug discovery
This is the latest episode of the free DDW narrated podcast, titled "How technology is impacting drug discovery", which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and The push towards lab automation in biopharma. In the first article, Andrew Radin, Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discovery’s most new and complex challenges. In the second article, DDW Editor Reece Armstrong speaks to Peter Walters, Director Advanced Therapies, CRB, and Grace Linton, Director Process Architecture, CRB about automation within laboratory settings and its effect on the pharmaceutical industry.

Aug 19, 2024 • 14min
DDW Highlights: 19 August 2024
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news highlights this week all feature advances in drug development in oncology indications and reflect the breadth of therapeutic approaches to cancer treatment. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Aug 12, 2024 • 10min
DDW Highlights: 12 August 2024
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news highlights this week all centre around significant US Food and Drug Administration (FDA) regulatory decisions, including new approvals for drugs for solid tumours, hepatitis B and glioma. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Aug 5, 2024 • 16min
DDW Highlights: 5 August 2024
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. GLP-1 receptor agonists have dominated the headlines this week, with data revealed on new potential beneficial effects of treatment with semaglutide and dual receptor agonists like pemvidutide. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Aug 1, 2024 • 32min
Innovation drivers and opportunities for drug discovery
This is the latest episode of the free DDW narrated podcast, titled "Innovation drivers and opportunities for drug discovery", which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How transcriptomics is driving drug discovery Scandinavia: Insight into opportunities for drug discovery In the first article, Svea Cheeseman from Refeyn explains why better efficiency is needed to advance the production of viral vectors for use in gene therapies. In the second article, Dr Stephen Barat, Senior Vice President and Therapeutics Division Head at HTG Molecular Diagnostics tells DDW how transcriptomics is driving drug discovery and precision medicines. In the third article, DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market.

Jul 29, 2024 • 12min
DDW Highlights: 29 July 2024
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. There have been some interesting developments in neuroscience this week. Perhaps most note-worthy, shingles vaccines Shingrix has been shown to reduce the risk of dementia by 17%, and TikoMed’s ALS drug caused a long-term slowing of ALS progression in a Phase II trial. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

Jul 25, 2024 • 33min
Where is the global innovation and the opportunity in CGTs?
This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The promise and growth of cell and gene therapies No sign of stopping: The rise of cell and gene therapy Expert view: What's next for cell and gene therapy? Understanding the future roadmaps of cell and gene therapy Under the microscope: Zoning in on the CGT sector In the first article, DDW's Megan Thomas comments on the state of the CGT industry. In the second, Ryan Leahy, a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. In the third, DDW's Megan Thomas explores the global innovations in cell and gene therapy and what opportunities and challenges are emerging and can therapies get to market faster. In the fourth, DDW's Megan Thomas caught up with George White, General Manager, Product Management, Cell & Gene Therapy at Cytiva, to learn more about the company’s insight into the CGT market. In the fifth and final article, IB Communications’ CEO Michelle Boxall explains why there are two sides to the cell and gene therapy coin.

Jul 22, 2024 • 13min
DDW Highlights: 22 July 2024
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news stories this week all feature therapies that could have significant impact on the future treatment of cancer, particularly haematological malignancies, but also solid tumours. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.